Annals of Clinical and Laboratory Research

  • ISSN: 2386-5180
  • Journal h-index: 19
  • Journal CiteScore: 5.42
  • Journal Impact Factor: 4.64
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
+44 7460731551
Awards Nomination
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Directory of Research Journal Indexing (DRJI)
  • Publons
  • Euro Pub
  • Google Scholar
  • Secret Search Engine Labs
  • Zenodo
Share This Page

Opinion - (2022) Volume 10, Issue 12

A Cutting-Edge Omics Technique used recently in the Study of Herbal Medicine: Metabolomics

Moses Isabel*
Department of Public Health, Erasmus MC University Medical Center, Rotterdam, Netherlands
*Correspondence: Moses Isabel, Department of Public Health, Erasmus MC University Medical Center, Rotterdam, Netherlands, Email:

Received: 10-Nov-2022, Manuscript No. IPACLR-22-13335; Editor assigned: 14-Nov-2022, Pre QC No. IPACLR-22-13335(PQ); Reviewed: 28-Nov-2022, QC No. IPACLR-22-13335; Revised: 02-Dec-2022, Manuscript No. IPACLR-22-13335(R); Published: 09-Dec-2022, DOI: 10.36648/2386-5180.22.10.449


Omics approaches, such as (meta) genomics for DNAs, transcriptomics for RNAs, proteomics for proteins, metabolomics for small hydrophilic compounds, and lipidomics for tiny lipophilic molecules, all aim to assess the entire composition of a particular biochemical group. This therapy option has not yet been refined into a specific clinical application, despite numerous studies still being conducted on it. Recent advancements in medical research and our understanding of biological systems have been made possible by omics, a high-throughput method for comprehending the genome, transcriptome, proteome, and metabolome. Advanced omics methods have been used to research numerous cancer immunotherapies, including multi-omics, singlecell omics, and conventional omics.


Our article aims to be both a review of the recent past and a forecast of what lies ahead for regenerative medicine. We attempt to predict the future by taking into account the rate of technological advancement over the last ten years. We also explore the evolving nature and pragmatic challenges of gynaecologic surgery for the conceptive endocrinology and fruitlessness subspecialist. We will make sense of how novel developments might alter our perceptions and presumptions regarding the indications, timing, and intensity of careful intercession in the patient seeking preservation of ripeness as well as the patient who is barren. This study does not aim to be exhaustive; rather, it focuses on those developments that, in our opinion, have a real chance of influencing the future of meticulous practise [1].

However, there are definite indications in the industry that the time has come for a mechanical insurgency in medical procedure. Approximately ten robot-aided surgical (RAS) products are being developed by as many organisations at this time. Future competition is expected to be fierce, with a strong focus on cost control and reduction. In all upcoming meticulous stages, we anticipate that mechanical tools and laparoscopic ports will be identical to the 5 mm laparoscopic ones [2].

The advancement of vision is expected to continue, with 4K visors presumably replacing the current 1080K visors. Nevertheless, the degree of lucidity we can achieve while scaling down laparoscopes may be constrained by actual limitations due to camera size and the need to keep up with stereoscopy. Brilliant vision and image fusion are likely to advance. The primary smart vision advancement currently available is firefly fluorescence imaging, which is compatible with the two most recent generations of the da Vinci robot. In the movie Firefly, a remarkable camera uses close-up infrared imaging to identify an infused tracer, indocyanine green, and exceptionally vascularized tissues. Firefly has a variety of uses, including highlighting lymph nodes and even ureters (with transurethral infusion via catheter/cystoscopy). It is difficult to imagine how comparative innovations could change the way we approach conditions like endometriosis for example, when fluorescence can be connected to explicit tissue markers [3, [4]. Despite the fact that there are few conceptual medical procedures that use fireflies. Future mechanical/non-automated stages can be expected to use picture fusion, where imported data from 3-layered (3D) ultrasound, 3D processed tomography, and attractive reverberation imaging is "locked" onto specific physical focuses that the robot can perceive during a medical procedure, taking into account picture scaling and constant 3D picture fusion. Applications for regenerative medicine could include extensive myoma planning in difficult different myomectomies, area of damaged adnexal, urological, and rectal life systems in difficult adhesiolysis, endometriosis extractions, and unexpected mullein inconsistency cases.

The business is sending out clear signals that the time has come for a mechanical insurgency in medical procedure. Approximately ten robot-aided surgical (RAS) products are being developed at the moment by as many organisations [5]. It is anticipated that future competition will be fierce, with a strong emphasis on cost control and reduction.


Recent advancements in various omics technologies have given plant scientists an unheard-of potential to gain significant biological knowledge by integrating study of various omics datasets. Genomes, transcriptomes, proteomes, metabolomes, and other omics datasets produced from different MPs have been described, and associated bioinformatic databases and tools have been created. For examining MPs, integrated analysis of multi-omics datasets is incredibly thorough. Results from multi-omics datasets offer a theoretical foundation for stable biotransformation of desired secondary metabolites using synthetic biology, as well as a platform for developing MP species with high yield, good quality, and disease resistance through molecular breeding.


  1. Mozumdar G, Liguori G (2011) Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006. Diabetes Care 34: 216-19.
  2. Indexed at, Google Scholar, Cross Ref

  3. Lin SH, Liu T, Ming X, Tang Z, Fu L, et al (2016).Regulatory role of hexosamine biosynthetic pathway on hepatic cancer stem cell marker CD133 under low glucose conditions. Sci Rep 6: 21184.
  4. Indexed at, Google Scholar, Cross Ref

  5. Saklayen MG (2018)The global epidemic of the metabolic syndrome. Curr Hypertens 20: 12.
  6. Indexed at, Google Scholar, Cross Ref

  7. Zhang H, Jia Y, Cooper JJ, Hale T, Zhang Z, et al (2004).Common variants in glutamine:fructose-6-phosphate amidotransferase 2 (GFPT2) gene are associated with type 2 diabetes, diabetic nephropathy, and increased GFPT2 mRNA levels. J Clin Endocrinol Metab 89: 748-55.
  8. Indexed at, Google Scholar, Cross Ref

  9. Kresovich JK, Zheng Y, Cardenas A, Joyce BT, Rifas-Shiman SL, et al (2017).Cord blood DNA methylation and adiposity measures in early and mid-childhood. Clin Epigenet 9: 86.
  10. Indexed at, Google Scholar, Cross Ref